IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models.
Front Immunol
; 14: 1165404, 2023.
Article
in En
| MEDLINE
| ID: mdl-37564658
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-15
/
Neoplasm Recurrence, Local
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Front Immunol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland